Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting

被引:6
作者
Fiorella, D. [1 ]
Turan, T. N. [2 ]
Derdeyn, C. P. [3 ]
Chimowitz, M. I. [2 ]
机构
[1] SUNY Stony Brook, Med Ctr, Dept Neurosurg, New York, NY USA
[2] Med Univ S Carolina, Div Neurol, Charleston, SC 29425 USA
[3] Washington Univ, Div Radiol Neurol & Neurosurg, St Louis, MO USA
关键词
TRANSIENT ISCHEMIC ATTACK; ANTITHROMBOTIC THERAPY; AGGRESSIVE REDUCTION; STROKE PREVENTION; WINGSPAN STENT; ANGIOPLASTY; STENOSIS; ASPIRIN; RISK; COMPLICATIONS;
D O I
10.1136/jnis.2009.000125
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis (SAMMPRIS) is a randomized trial comparing aggressive medical management alone with aggressive medical management in combination with angioplasty and stenting using the Gateway-Wingspan system in patients with symptomatic, high-grade, intracranial stenosis. This trial represents a landmark in the maturation of the field of neurointervention, establishing a foundation for evidenced-based practice. We review the natural history of symptomatic intracranial stenosis when treated medically, the available interventional therapies and the rationale for the design of the SAMMPRIS trial.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 33 条
[1]   Drug-eluting stents for the treatment of intracranial atherosclerosis - Initial experience and midterm angiographic follow-up [J].
Abou-Chebl, A ;
Bashir, Q ;
Yadav, JS .
STROKE, 2005, 36 (12) :165-168
[2]  
Abruzzo TA, 2007, AM J NEURORADIOL, V28, P808
[3]   Angiographic patterns of Wingspan in-stent restenosis [J].
Albuquerque, Felipe C. ;
Levy, Elad I. ;
Turk, Aquilla S. ;
Niemann, David B. ;
Aagaard-Kienitz, Beverly ;
Pride, G. Lee, Jr. ;
Purdy, Phillip D. ;
Welch, Babu C. ;
Woo, Henry H. ;
Rasmussen, Peter A. ;
Hopkins, L. Nelson ;
Masaryk, Thomas J. ;
McDougall, Cameron G. ;
Fiorella, David J. .
NEUROSURGERY, 2008, 63 (01) :23-27
[4]   Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack - The stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial [J].
Amarenco, Pierre ;
Goldstein, Larry B. ;
Szarek, Michael ;
Sillesen, Henrik ;
Rudolph, Amy E. ;
Callahan, Alfred, III ;
Hennerici, Michael ;
Simunovic, Lisa ;
Zivin, Justin A. ;
Welch, K. Michael A. .
STROKE, 2007, 38 (12) :3198-3204
[5]   Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes [J].
Amarenco, Pierre ;
Benavente, Oscar ;
Goldstein, Larry B. ;
Callahan, Alfred, III ;
Sillesen, Henrik ;
Hennerici, Michael G. ;
Gilbert, Steve ;
Rudolph, Amy E. ;
Simunovic, Lisa ;
Zivin, Justin A. ;
Welch, K. Michael A. .
STROKE, 2009, 40 (04) :1405-1409
[7]   A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses - The Wingspan study [J].
Bose, Arani ;
Hartmann, Marius ;
Henkes, Hans ;
Liu, Hon Man ;
Teng, Michael M. H. ;
Szikora, Istvan ;
Berlis, Ansgar ;
Reul, Jurgen ;
Yu, Simon C. H. ;
Forsting, Michael ;
Lui, Matt ;
Lim, Winston ;
Sit, Siu Po .
STROKE, 2007, 38 (05) :1531-1537
[8]   Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation [J].
Chalmers, J ;
MacMahon, S .
JOURNAL OF HYPERTENSION, 2003, 21 :S9-S14
[9]   Risk factor status and vascular events in patients with symptomatic intracranial stenosis [J].
Chaturvedi, S. ;
Turan, T. N. ;
Lynn, M. J. ;
Kasner, S. E. ;
Romano, J. ;
Cotsonis, G. ;
Frankel, M. ;
Chimowitz, M. I. .
NEUROLOGY, 2007, 69 (22) :2063-2068
[10]   Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis [J].
Chimowitz, MI ;
Lynn, MJ ;
Howlett-Smith, H ;
Stern, BJ ;
Hertzberg, VS ;
Frankel, MR ;
Levine, SR ;
Chaturvedi, S ;
Kasner, SE ;
Benesch, CG ;
Sila, CA ;
Jovin, TG ;
Romano, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (13) :1305-1316